Profile for European Patent Office Patent: 3919048
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for European Patent Office Patent: 3919048
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,980,795 | Jun 12, 2033 | Ipsen | ONIVYDE | irinotecan hydrochloride |
| 11,369,597 | Jun 12, 2033 | Ipsen | ONIVYDE | irinotecan hydrochloride |
| 9,339,497 | Jun 12, 2033 | Ipsen | ONIVYDE | irinotecan hydrochloride |
| 9,364,473 | Jun 12, 2033 | Ipsen | ONIVYDE | irinotecan hydrochloride |
| 9,452,162 | Jun 12, 2033 | Ipsen | ONIVYDE | irinotecan hydrochloride |
| 9,492,442 | Jun 12, 2033 | Ipsen | ONIVYDE | irinotecan hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
